Potential Protective Effects of Probiotics and Prebiotics Against Colorectal Cancer

  • Philip Allsopp
  • Ian Rowland


Colorectal cancer (CRC) is the fourth most frequent cause of cancer related mortality in the world. Approximately 944,000 new cases were diagnosed globally in 2000 and this accounts for 9.2% of all new cancer cases (IARC, 2000). In Western societies namely Europe, North America and Australasia, it is the second most prevalent cancer after lung/breast (Boyle and Langman, 2000). About 363,000 new cases were reported in Europe in 2000 and it affects 6% of men and women by age 75, in almost equal proportion.


Lactic Acid Bacterium Resistant Starch Aberrant Crypt Focus Lactic Acid Bacterium Strain Fermented Dairy Product 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

List of Abbreviations


aberrant crypt foci




Colorectal cancer










human flora associated




lactic acid producing bacteria








non-digestible oligosaccharide




trans-galactosylated oligosaccharide






  1. Abdelali H, Cassand P, Soussotte V, Daubeze M, Bouley C, Narbonne JF (1995) Effect of dairy products on initiation of precursor lesions of colon cancer in rats. Nutr Cancer 24:121–132Google Scholar
  2. Archer S, Hodin R (1999) Histone acetylation and cancer. Curr Opin Genet Dev 9:171–174Google Scholar
  3. Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S (1995) Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double – blind trial. Eur Urol 27:104–109Google Scholar
  4. Ayebo AD, Angelo IA, Shahani KM (1980) Effect of ingesting Lactobacillus acidophilus milk upon fecal flora and enzyme activity in humans. Milchwissenschaft 35:730–733Google Scholar
  5. Basson M, Liu YW, Hanly A, Emenecker N, Shenoy S, Gould, Rothberg BE (2000) Identification and comparative analysis of human short chain fatty acid response genes. J Gast Surg 4:501–502Google Scholar
  6. Bertazzoni-Minelli E, Benini A, Vicentini L, Andreoli E, Oselladore M, Cerutti R (1996) Effect of Lactobacillus acidophilus and Bifidobacterium bifidum administration on colonic microbiota and its metabolic activity in premenstrual syndrome. Microb Ecol Health Dis 9:247–260Google Scholar
  7. Biasco G, Paganelli GM, Brandi G, Brillanti S, Lami F, Callegari C, Gizzi G (1991) Effect of Lactobacillus acidophilus and Bifidobacterium bifidum on rectal cell kinetics. Ital J Gastroenterol 23:142Google Scholar
  8. Bolognani F, Rumney CJ, Pool-Zobel BL, Rowland IR (2001) Effect of lactobacilli, bifidobacteria and inulin on the formation of aberrant crypt foci in rats. Eur J Nutr 40:293–300Google Scholar
  9. Bolognani F, Rumney CJ, Rowland IR (1997) Influence of carcinogen binding by lactic acid producing bacteria on tissue distribution and in vivo mutagenicity of dietary carcinogens. Food Chem Toxicol 35:535–545Google Scholar
  10. Borruel N, Carol M, Casellas F, Antolin M, de Lara, Espin E, Naval J, Guarner F, Malagelada JR (2002) Increased mucosaltumour necrosis factor production in Crohns disease can be down regulated ex vivo by probiotic bacteria. Gut 51659–51664Google Scholar
  11. Boutron MC, Faivre J, Marteau P, Couillault C, Senesse P, Quipourt V (1996) Calcium, phosphorous, vitamin D, dairy products and colorectal carcinogenesis: a French case-control study. Br J Cancer 74:145–151Google Scholar
  12. Boutron-Ruault MC, Marteau P, Lavergne-Slove A, Myara A, Gerhardt MF, Franchisseur C, Bornet F (2005) Effects of a 3-mo consumption of short-chain fructo-oligosaccharides on parameters of colorectal carcinogenesis in patients with or without small or large colorectal adenomas. Nutr Cancer 53(2):160–168Google Scholar
  13. Boyle P, Langman JS (2000) ABC of colorectal cancer – epidemiology. Br Med J 321:805–808Google Scholar
  14. Buddington KK, Donahoo JB, Buddington RK (2002) Dietary oligofructose and inulin protect mice from enteric and systemic pathogens and tumor inducers. J Nutr 132(3):472–477Google Scholar
  15. Burns AJ, Rowland IR (2004) Antigenotoxicity of probiotics and prebiotics on fecal water-induced DNA damage in human colon adenocarcinoma cells. Mutat Res 551(1–2):233–243Google Scholar
  16. Caderni G, Femia AP, Giannini A, Favuzza A, Luceri C, Salvadori M, Dolara P (2003) Identification of mucin depleted foci in the unsectioned colon of azoxymethane treated rats: correlation with carcinogenesis. Cancer Res 63:2388–2392Google Scholar
  17. Caldini G, Trotta F, Corsetti A, Cenci G (2008) Evidence for in vitro anti-genotoxicity of cheese non-starter lactobacilli. Antonie Van Leeuwenhoek 93(1–2):51–59Google Scholar
  18. Caldini G, Trotta F, Villarini M, Moretti M, Pasquini R, Scassellati-Sforzolini G, Cenci G (2005) Screening of potential lactobacilli antigenotoxicity by microbial and mammalian cell-based tests. Int J Food Microbiol 102(1):37–47Google Scholar
  19. Carman RJ, Vantassell RL, Kingston DGI, Bashir M, Wilkins TD (1988) Conversion of IQ, a dietary pyrolysis carcinogen to a direct acting mutagen by normal intestinal bacteria of humans. Mutat Res 206:335–342Google Scholar
  20. Cenci G, Caldini G, Trotta F, Bosi P (2008) In vitro inhibitory activity of probiotic spore-forming bacilli against genotoxins. Lett Appl Microbiol 46(3):331–337Google Scholar
  21. Cenci G, Rossi J, Trotta F, Caldini G (2002) Lactic acid bacteria isolated from dairy products inhibit genotoxic effect of 4-nitroquinoline-1-oxide in SOS-chromotest. Syst Appl Microbiol 25(4):483–490Google Scholar
  22. Challa A, Rao DR, Chawan CB, Shackelford L (1997) Bifidobacterium longum and lactulose suppress azoxymethane induced aberrant crypt foci in rats. Carcinogenesis 18:517–521Google Scholar
  23. Chinthalapally R, Sanders M, Indranie C, Simi B, Reddy B (1999) Prevention of preneoplastic lesions by the probiotic Lactobacillus acidophilus NCFMTM in F344 rats. Int J Oncol 14:939–944Google Scholar
  24. Choi SS, Kang BY, Chung MJ, Kim SD, Park SH, Kim JS, Kang CY, Ha NJ (2005) Safety assessment of potential lactic acid bacteria Bifidobacterium longum SPM1205 isolated from healthy Koreans. J Microbiol 43(6):493–498Google Scholar
  25. Cole CB, Fuller R, Carter SM (1989) Effect of probiotic supplements of Lactobacillus acidophilus and Bifidobacterium adolescentis 2204 on β-glucosidase and β-glucuronidase activity in the lower gut of rats associated with a human fecal flora. Microb Ecol Health Dis 2:223–225Google Scholar
  26. Commane DM, Shortt CT, Silvi S, Cresci A, Hughes RM, Rowland IR (2005) Effects of fermentation products of pro- and prebiotics on transepithelial resistance in an in vitro model of the colon. Nutr Cancer 51:102–109Google Scholar
  27. Corsetti A, Caldini G, Mastrangelo M, Trotta F, Valmorri S, Cenci G (2008) Raw milk traditional Italian ewe cheeses as a source of Lactobacillus casei strains with acid-bile resistance and antigenotoxic properties. Int J Food Microbiol 125(3):330–335Google Scholar
  28. Ebringer L, Ferencik M, Lahitova N, Kacani L, Michalkova D (1995) Anti-mutagenic and immuno-stimulatory properties of lactic acid bacteria. World J Microbiol Biotechnol 11:294–298Google Scholar
  29. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759–767Google Scholar
  30. Femia AP, Luceri C, Dolara P, Giannini A, Biggeri A, Salvadori M, Clune Y, Collins KJ, Paglierani M, Caderni G (2002) Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane induced colon carcinogenesis in rats. Carcinogenesis 23:1953–1960Google Scholar
  31. Fukui M, Fujino T, Tsutsui K, Maruyama T, Yoshimura H, Shinohara T, Fukui M, Nada O (2001) The tumor-preventing effect of a mixture of several lactic acid bacteria on 1,2-dimethylhydrazine-induced colon carcinogenesis in mice. Oncol Rep 8(5):1073–1078Google Scholar
  32. Gallaher DD, Stallings WH, Blessing LL, Busta FF, Brady LJ (1996) Probiotics cecal microflora, and aberrant crypts in the rat colon. J Nutr 126:1362–1371Google Scholar
  33. Garcia Lafuente A, Antolin M, Guarner F, Crespo E, Malagelada JR (2001) Modulation of colonic barrier function by the composition of the commensal flora in the rat. Gut 48:503–507Google Scholar
  34. Gill CI, Heavey P, McConville E, Bradbury I, Fassler C, Mueller S, Cresci A, Dore J, Norin E, Rowland I (2007) Effect of fecal water on an in vitro model of colonic mucosal barrier function. Nutr Cancer 57:59–65Google Scholar
  35. Gill HS, Rutherford KJ, Cross ML, Gopal PK (2001) Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr 74:833–839Google Scholar
  36. Glinghammar B, Venturi M, Rowland IR, Rafter JJ (1997) Shift from a dairy product-rich to a dairy product-free diet: influence on cytotoxicity and genotoxicity of fecal water-potential risk factors for colon cancer. Am J Clin Nutr 66:1277–1282Google Scholar
  37. Goldin BR, Gorbach SL (1976) The relationship between diet and rat fecal bacterial enzymes implicated in colon cancer. J Natl Cancer Inst 57:371–375Google Scholar
  38. Goldin BR, Gorbach SL (1980) Effect of Lactobacillus acidophilus dietary supplements on 1,2-dimethylhydrazine dichloride-induced intestinal cancer in rats. J Natl Cancer Inst 64:263–265Google Scholar
  39. Goldin BR, Gorbach SL (1984a) Alterations of the intestinal microflora by diet, oral antibiotics, and Lactobacillus: decreased production of free amines from aromatic nitro compounds, azo dyes, and glucuronides. J Natl Cancer Inst 73:689–695Google Scholar
  40. Goldin BR, Gorbach SL (1984b) The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity. Am J Clin Nutr 39:756–761Google Scholar
  41. Goldin BR, Gualtieri LJ, Moore RP (1996) The effect of Lactobacillus GG on the initiation and promotion of DMH – induced intestinal tumours in the rat. Nutr Cancer 25:197–204Google Scholar
  42. Gostner A, Blaut M, Schäffer V, Kozianowski G, Theis S, Klingeberg M, Dombrowski Y, Martin D, Ehrhardt S, Taras D, Schwiertz A, Kleessen B, Lührs H, Schauber J, Dorbath D, Menzel T, Scheppach W (2006) Effect of isomalt consumption on fecal microflora and colonic metabolism in healthy volunteers. Br J Nutr 95(1):40–50Google Scholar
  43. Haberer P, du Toit M, Dicks LMT, Ahrens F, Holzapfel WH (2003) Effect of potentially probiotic lactobacilli on fecal enzyme activity in minipigs on a high-fat, high-cholesterol diet-a preliminary in vivo trial. Int J Food Microbiol 87(3):287–291Google Scholar
  44. Hague A, Manning A, Hanlon K, Huschtcha L, Hart D, Paraskeva C (1993) Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53 independent pathway implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer 55:498–505Google Scholar
  45. Hayakawa K, Mizutani J, Wada K, Masai T, Yoshihara I, Mitsuoka T (1990) Effects of soybean oligosaccharides on human fecal microflora. Microb Ecol Health Dis 3:293–303Google Scholar
  46. Hayatsu H, Hayatsu T (1993) Suppressing effect of Lactobacillus casei administration on the urinary mutagenicity arising from ingestion of fried ground beef in the human. Cancer Lett 73:173–179Google Scholar
  47. Holzapfel WH, Haberer P, Snel J, Schillinger U, Huis_in_t_Veld JH (1998) Overview of gut flora and probiotics. Int J Food Microbiol 41:85–101Google Scholar
  48. Horie H, Zelsig M, Hitayama K, Midtvedt I, Moller L, Raffer J (2003) Probiotic mixture decreases DNA adduct formation in colonic epithelium induced by the food mutagen 2-amino-9H-pyrido[2,3-b]indole in a human-florn associated mouse model. Eur J Cancer Prev 12:101–107Google Scholar
  49. Hsu CK, Liao JW, Chung YC, Hsieh CP, Chan YC (2004) Xylooligosaccharides and fructooligosaccharides affect the intestinal microbiota and precancerous colonic lesion development in rats. J Nutr 134(6):1523–1538Google Scholar
  50. Huang Y, Kotula L, Adams MC (2003) The in vivo assessment of safety and gastrointestinal survival of an orally administered novel probiotic, Propionibacterium jensenii 702, in a male Wistar rat model. Food Chem Toxicol 41(12):1781–1787Google Scholar
  51. Hughes R, Kurth MJ, McGilligan V, McGlynn H, Rowland I (2008) Effect of colonic bacterial metabolites on Caco-2 cell paracellular permeability in vitro. Nutr Cancer 60(2):259–266Google Scholar
  52. Hughes R, Rowland I (2003) Nutritional and microbial modification of carcinogenesis. In: Fuller R, Perdigon G (eds) Gut flora, nutrition, immunity and health. Blackwell Publishing, Oxford, pp. 208–236Google Scholar
  53. Hughes RM, Rowland IR (2001) Stimulation of apoptosis by two prebiotic chicory fructans in the rat colon. Carcinogenesis 22:43–47Google Scholar
  54. IARC (1997) Cancer incidence in five continents, vol. VII. Iarc Scientific Publications, France, pp. i–xxxiv, 1–1240Google Scholar
  55. IARC (2000) GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence. Worldwide: International Agency for Research on Cancer (IARC), OxfordGoogle Scholar
  56. Ishikawa H, Akedo I, Otani T, Suzuki T, Nakamura T, Takeyama I, Ishiguro S, Miyaoka E, Sobue T, Kakizoe T (2005) Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int J Cancer 116:762–767Google Scholar
  57. Jacobsen H, Poulsen M, Dragsted LO, Ravn-Haren G, Meyer O, Lindecrona RH (2006) Carbohydrate digestibility predicts colon carcinogenesis in azoxymethane-treated rats. Nutr Cancer 55(2):163–170Google Scholar
  58. Kajander K, Krogius-Kurikka L, Rinttilä T, Karjalainen H, Palva A, Korpela R (2007) Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome. Aliment Pharmacol Ther 26(3):463–473Google Scholar
  59. Kampman E, Giovanucci P, Rimm E, Stampfer MJ, Colditz GA, Kok FJ, Willett WC (1994a) Calcium, vitamin D, dairy foods, and the occurrence of colorectal adenomas among men and women in two prospective studies. Am J Epidem 139:16–29Google Scholar
  60. Kampman E, van’t Veer P, Hiddink GJ, van Aken-Schneijder P, Kok FJ, Hermus RJ (1994b) Fermented dairy products, dietary calcium and colon cancer: a case-control study in the Netherlands. Int J Cancer 59:170–176Google Scholar
  61. Kennedy RJ, Hoper M, Weir H (2000) Probiotic therapy stabilizes the gut mucosal barrier in the IL10 knockout mouse model of ulcerative colitis (abstract). Br J Surg 87:699Google Scholar
  62. Klinder A, Förster A, Caderni G, Femia AP, Pool-Zobel BL (2004) Fecal water genotoxicity is predictive of tumor-preventive activities by inulin-like oligofructoses, probiotics (Lactobacillus rhamnosus and Bifidobacterium lactis), and their synbiotic combination. Nutr Cancer 49(2):144–155Google Scholar
  63. Koller VJ, Marian B, Stidl R, Nersesyan A, Winter H, Simić T, Sontag G, Knasmüller S (2008) Impact of lactic acid bacteria on oxidative DNA damage in human derived colon cells. Food Chem Toxicol 46(4):1221–1229Google Scholar
  64. Kulkarni N, Reddy BS (1994) Inhibitory effect of Bifidobacterium longum cultures on the azoxymethane induced aberrant crypt foci formation and fecal bacterial β-glucuronidase. Proc Soc Exp Biol Med 207:278–283Google Scholar
  65. Lee NK, Park JS, Park E, Paik HD (2007) Adherence and anticarcinogenic effects of Bacillus polyfermenticus SCD in the large intestine. Lett Appl Microbiol 44(3):274–278Google Scholar
  66. Le Leu RK, Brown IL, Hu Y, Bird AR, Jackson M, Esterman A, Young GP (2005) A synbiotic combination of resistant starch and Bifidobacterium lactis facilitates apoptotic deletion of carcinogen-damaged cells in rat colon. J Nutr 135:996–1001Google Scholar
  67. Li W, Li CB (2003) Lack of inhibitory effects of lactic acid bacteria on 1,2-dimethylhydrazine-induced colon tumors in rats. World J Gastroenterol 9(11):2469–2473Google Scholar
  68. Lidbeck A, Geltner Allinger U, Orrhage KM, Ottova L, Brismar B, Gustafsson JA, Rafter JJ, Nord CE (1991) Impact of Lactobacillus acidophilus supplements on the fecal microflora and soluble fecal bile acids in colon cancer patients. Microb Ecol Health Dis 4:81–88Google Scholar
  69. Lidbeck A, Nord CE, Gustafsson JA, Rafter J (1992) Lactobacilli, anticarcinogenic activities and human intestinal microflora. Eur J Cancer Prev 1:341–353Google Scholar
  70. Lo PR, Yu RC, Chou CC, Huang EC (2004) Determinations of the antimutagenic activities of several probiotic bifidobacteria under acidic and bile conditions against benzo[a]pyrene by a modified Ames test. Int J Food Microbiol 93(2):249–257Google Scholar
  71. Macfarlane GT, Gibson G (1995) Microbiological aspects of the production of short chain fatty acids in the large bowel. In: Cummings JH, Rombeau JL, Sakata T (eds) Physiological and clinical aspects of short chain fatty acids. University Press, Cambridge, pp. 87–107Google Scholar
  72. Madrigal-Santillán E, Madrigal-Bujaidar E, Márquez-Márquez R, Reyes A (2006) Antigenotoxic effect of Saccharomyces cerevisiae on the damage produced in mice fed with aflatoxin B1 contaminated corn. Food Chem Toxicol 44(12):2058–2063Google Scholar
  73. Mallett AK, Rowland IR (1988) Factors affecting the gut microflora. In: Rowland IR (ed) Role of the gut flora in toxicity and cancer. Academic Press, London, pp. 347–382Google Scholar
  74. Marotta F, Naito Y, Minelli E, Tajiri H, Bertuccelli J, Wu CC, Min CH, Hotten P, Fesce E (2003) Chemopreventive effect of a probiotic preparation on the development of preneoplastic and neoplastic colonic lesions: an experimental study. Hepatogastroenterology 50(54):1914–1918Google Scholar
  75. Marteau P, Pochart P, Flourie B, Pellier P, Santos L, Desjeux J-F, Rambaud J-C (1990) Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans. Am J Clin Nutr 52:685–688Google Scholar
  76. Marteau P, Vaerman JP, Dehennin JP, Bord S, Brassart D, Pochart P, Desjeux JF, Rambeau JC (1997) Effects of intrajejunal perfusion and chronic ingestion of Lactobacillus johnsonii strain La1 on serum concentrations and jejunal secretions of immunoglobulins and serum proteins in healthy humans. Gastroenterol Clin Biol 21:293–298Google Scholar
  77. Massey RC, Key PE, Mallett AK, Rowland IR (1988) An investigation of the endogenous formation of apparent total N-nitroso compounds in conventional microflora and germ-free rats. Food Chem Toxicol 26:595–600Google Scholar
  78. Matsuzaki T, Chin J (2000) Modulating immune responses with probiotic bacteria, immunol. Cell Biol 78:67–73Google Scholar
  79. McIntosh GH, Royle PJ, Playne MJ (1999) A probiotic strain of L. acidophilus reduces DMH-induced large intestinal tumors in male Sprague-Dawley rats. Nutr Cancer 35:153–159Google Scholar
  80. de Moreno de LeBlanc A, Perdigón G (2005) Reduction of beta-glucuronidase and nitroreductase activity by yoghurt in a murine colon cancer model. Biocell 1:15–24Google Scholar
  81. Morotomi M, Mutai M (1986) In vitro binding of potent mutagenic pyrolyzates to intestinal bacteria. J Natl Cancer Inst 77:195–201Google Scholar
  82. Mutanen M, Pajari AM, Oikarinen SI (2000) Beef induces and rye bran prevents the formation of intestinal polyps in Apc(Min) mice: relation to beta-catenin and PKC isozymes. Carcinogenesis 21:1167–1173Google Scholar
  83. Nagao F, Nakayama M, Muto T, Okomura K (2000) Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects. Biosci Biotechnol Biochem 64:2706–2708Google Scholar
  84. Nakanishi S, Kataoka K, Kuwahara T, Ohnishi Y (2003) Effects of high amylose maize starch and Clostridium butyricum on metabolism in colonic microbiota and formation of azoxymethane-induced aberrant crypt foci in the rat colon. Microbiol Immunol 47(12):951–958Google Scholar
  85. Nersesyan A (2001) Antigenotoxic action of “Narine” Lactobacilli in rat colon cells in vitro. Exp Oncol 23:297–298Google Scholar
  86. Oberreuther-Moschner DL, Jahreis G, Rechkemmer G, Pool-Zobel BL (2004) Dietary intervention with the probiotics Lactobacillus acidophilus 145 and Bifidobacterium longum 913 modulates the potential of human fecal water to induce damage in HT29clone19A cells. Br J Nutr 91(6):925–932Google Scholar
  87. Ohkawara S, Furuya H, Nagashima K, Asanuma N, Hino T (2005) Oral administration of butyrivibrio fibrisolvens, a butyrate-producing bacterium, decreases the formation of aberrant crypt foci in the colon and rectum of mice. J Nutr 135(12):2878–2883Google Scholar
  88. Orrhage K, Sillerstrom E, Gustafsson J-Å, Nord CE, Rafter J (1994) Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria. Mutat Res 311:239–248Google Scholar
  89. Ouwehand AC, Lagström H, Suomalainen T, Salminen S (2002) Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Ann Nutr Metab 46(3–4):159–162Google Scholar
  90. Pajari AM, Rajakangas J, Päivärinta E, Kosma VM, Rafter J, Mutanen M (2003) Promotion of intestinal tumor formation by inulin is associated with an accumulation of cytosolic beta-catenin in Min mice. Int J Cancer 106:653–660Google Scholar
  91. Park E, Jeon GI, Park JS, Paik HD (2007) A probiotic strain of Bacillus polyfermenticus reduces DMH induced precancerous lesions in F344 male rat. Biol Pharm Bull 30(3):569–574Google Scholar
  92. Pawłowska J, Klewicka E, Czubkowski P, Motyl I, Jankowska I, Libudzisz Z, Teisseyre M, Gliwicz D, Cukrowska B (2007) Effect of Lactobacillus casei DN-114001 application on the activity of fecal enzymes in children after liver transplantation. Transplant Proc 39(10):3219–3221Google Scholar
  93. Perdigon G, Valdez JC, Rachid M (1998) Antitumour activity of yoghurt: study of possible immune mechanisms. J Dairy Res 65:129–138Google Scholar
  94. Perrin P, Pierre F, Patry Y, Champ M, Berreur M, Pradal G, Bornet F, Meflah K, Menanteau J (2001) Only fibres promoting a stable butyrate producing colonic ecosystem decrease the rate of aberrant crypt foci in rats. Gut 48:53–61Google Scholar
  95. Peters RK, Pike MC, Garabrant D, Mack TM (1992) Diet and colon cancer in Los Angeles County, California. Cancer Cause Control 3:457–473Google Scholar
  96. Pierre F, Perrin P, Champ M, Bornet F, Meflah K, Menanteau J (1997) Short-chain fructo-oligosaccharides reduce the occurrence of colon tumours and develop gut associated lymphoid tissue in Min mice. Cancer Res 57:225–228Google Scholar
  97. Ponz de Leon M, Roncucci L (2000) The cause of colorectal cancer. Dig Liver Dis 32:426–439Google Scholar
  98. Pool-Zobel BL, Munzner R, Holzaapfel H (1993) Antigenotoxic properties of lactic acid bacteria in the S. typhimurium Mutagenicity assay. Nutr Cancer 20:261–270Google Scholar
  99. Pool-Zobel BL, Neudecker C, Domizlaff I, Ji S, Schillinger U, Rumney C, Moretti M, Vilarini I, Scasellati-Sforzolini R, Rowland IR (1996) Lactobacillus and Bifidobacterium mediated antigenotoxicity in the colon of rats. Nutr Cancer 26:365–380Google Scholar
  100. Poulsen M, Mølck AM, Jacobsen BL (2002) Different effects of short- and long-chained fructans on large intestinal physiology and carcinogen-induced aberrant crypt foci in rats. Nutr Cancer 42(2):194–205Google Scholar
  101. de Preter V, Vanhoutte T, Huys G, Swings J, Rutgeerts P, Verbeke K (2008) Baseline microbiota activity and initial bifidobacteria counts influence responses to prebiotic dosing in healthy subjects. Aliment Pharmacol Ther 27(6):504–513Google Scholar
  102. Pretlow TP, O’Riordan MA, Somitch GA, Amini SB, Pretlow TG (1992) Aberrant crypts correlate with tumour incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis 13:1509–1512Google Scholar
  103. Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson PC, Klinder A, O’Riordan M, O’Sullivan GC, Pool-Zobel B, Rechkemmer G, Roller M, Rowland I, Salvadori M, Thijs H, Van Loo J, Watzl B, Collins JK (2007) Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am J Clin Nutr 85(2):488–496Google Scholar
  104. Raipulis J, Toma MM, Semjonovs P (2005) The effect of probiotics on the genotoxicity of furazolidone. Int J Food Microbiol 102(3):343–347Google Scholar
  105. Rao CV, Chou D, Simi B, Ku H, Reddy BS (1998) Prevention of colonic aberrant crypt foci and modulation of large bowel microbial activity by dietary coffee fiber, inulin and pectin. Carcinogenesis 19:1815–1819Google Scholar
  106. Reddy BS, Narisawa T, Wright P, Vukusich D, Weisburger JH, Wynder EL (1975) Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats. Cancer Res 35:287–290Google Scholar
  107. Reddy BS, Rivenson A (1993) Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5,-f]quinoline, a food mutagen. Cancer Res 53:3914–3918Google Scholar
  108. Reddy BS, Hamid R, Rao CV (1997) Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. Carcinogenesis 18:1371–1374Google Scholar
  109. Roller M, Femia AP, Caderni G, Rechkemmer G, Watzl B (2004) Intestinal immunity of rats with colon cancer is modulated by oligofructose-enriched inulin combined with Lacobacillus rhamnosus and Bifidobacterium lactis. Br J Nutr 92:931–938Google Scholar
  110. Rowland IR, Tanaka R (1993) The effects of transgalactosylated oligosaccharides on gut flora metabolism in rats associated with a human fecal microflora. J Appl Bact 74:667–674Google Scholar
  111. Rowland IR, Bearne CA, Fischer R, Pool-Zobel BL (1996) The effect of lactulose on DNA damage induced by DMH in the colon of human flora associated rats. Nutr Cancer 26:37–47Google Scholar
  112. Rowland IR (1995) Toxicology of the colon – role of the intestinal microflora. In: Macfarlane GT, Gibson G (ed) Human colonic bacteria, role in nutrition, physiology and pathology. CRC Press, Boca Raton, FL, pp. 155–174Google Scholar
  113. Rowland IR, Rumney CJ, Coutts JT, Lievense LC (1998) Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 19:281–285Google Scholar
  114. Rowland IR, Gangolli SD (1999) Role of gastrointestinal flora in the metabolic and toxicological activities of xenobiotics. In: Ballantyne B, Marrs TC, Syverson T (eds) General and applied toxicology, 2nd edn. Macmillan Publishers Ltd., London, pp. 561–576Google Scholar
  115. Rowland IR (2008) The role of the gastrointestinal microflora in colorectal cancer. Current Pharmaceutical Design 15 (in press)Google Scholar
  116. Rumney CJ, Rowland IR, Coutts TM, Randerath K, Reddy R, Shah AB, Ellul A, O’Neill IK (1993) Effects of risk-associated human dietary macrocomponents on processes related to carcinogenesis in human-flora-associated (HFA) rats. Carcinogenesis 14:79–84Google Scholar
  117. Saito Y, Takano T, Rowland IR (1992) Effects of soybean oligosaccharides on the human gut microflora in in vitro culture. Microb Ecol Health Dis 5:105–110Google Scholar
  118. Schiffrin E, Rochat F, link-Amster H, Aeschlimann J, Donnet-Hughes A (1996) Immunomodulation of blood cells following ingestion of lactic acid bacteria. J Dairy Sci 78:491–497Google Scholar
  119. Shih IM, Wang TL, Traverso G, Romans K, Hamilton SR, Ben-sasson A, Kinzler KW, Vogelstein B (2001) Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci USA 98:2640–2645Google Scholar
  120. Spanhaak S, Havenaar R, Schaafsma G (1998) The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr 52:899–907Google Scholar
  121. Takagi A, Takeshi M, Sato M, Nomoto K, Morotomi M, Yokokura T (2001) Enhancement of natural killer cell cytotoxicity delayed murine carcinogenesis by a probiotic microorganism. Carcinogenesis 22:599–605Google Scholar
  122. Sung HY, Choi YS (2008) Fructooligosaccharide and soy isoflavone suppress colonic aberrant crypt foci and cyclooxygenase-2 expression in dimethylhydrazine-treated rats. J Med Food 11(1):78–85Google Scholar
  123. Takeuchi H, Maehara Y, Tokunaga E, Koga T, Kakeji Y, Sugimachi K (2001) Prognostic significance of natural killer cell activity in patients with gastric carcinoma: A multivariate analysis. Am J Gastroenterol 96:574–578Google Scholar
  124. Tanaka R, Takayama H, Morotomi M, Kuroshima T, Ueyama S, Matsumoto K, Kuroda A, Mutai M (1983) Effects of administration of TOS and Bifidobacterium breve 4006 on the human fecal flora. Bifidobacteria Microflora 2:17–24Google Scholar
  125. Taper HS, Roberfroid M (1999) Influence of inulin and oligofructose on breast cancer and tumor growth. J Nutr 129:1488S–1491SGoogle Scholar
  126. Taper HS, Roberfroid MB (2005) Possible adjuvant cancer therapy by two prebiotics – inulin or oligofructose. In vivo. 19(1):201–4Google Scholar
  127. Toma MM, Raipulis J, Kalnina I, Rutkis R (2005) Does probiotic act as a Genotoxicin. Food Technol Biotechnol 43(3):301–305Google Scholar
  128. Tokunga T, Oku T, Hoysoya N (1986) Influence of chronic intake of new sweetener fructooligosaccharide (Neosugar) on growth and gastrointestinal function of the rat. J Nutr Sci Vitaminol 32:111–121Google Scholar
  129. Venturi M, Hambly RJ, Glinghammar B, Rafter JJ, Rowland IR (1997) Genotoxic activity in human fecal water and the role of bile acids: a study using the alkaline comet assay. Carcinogenesis 18:2353–2359Google Scholar
  130. Van’t Veer P, Dekker JM, Lamers JWJ, Kok FJ, Schouten EG, Brants HAM, Sturmans F, Hermus RJJ (1989) Consumption of fermented milk products and breast cancer: a case-control study in the Netherlands. Cancer Res 49:4020–4023Google Scholar
  131. Verghese M, Rao DR, Chawan CB, Shackelford L (2002b) Dietary inulin suppresses azoxymethane-induced preneoplastic aberrant crypt foci in mature Fisher 344 rats. J Nutr 132(9):2804–2808Google Scholar
  132. Verghese M, Rao DR, Chawan CB, Williams LL, Shackelford L (2002a) Dietary inulin suppresses azoxymethane-induced aberrant crypt foci and colon tumors at the promotion stage in young Fisher 344 rats. J Nutr 132(9):2809–2813Google Scholar
  133. Villarini M, Caldini G, Moretti M, Trotta F, Pasquini R, Cenci G (2008) Modulatory activity of a Lactobacillus casei strain on 1,2-dimethylhydrazine-induced genotoxicity in rats. Environ Mol Mutagen 49(3):192–199Google Scholar
  134. World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the preventionof cancer: a global perspective. AICR: Washington, DCGoogle Scholar
  135. Yamazaki K, Tsunoda A, Sibusawa M, Tsunoda Y, Kusano M, Fukuchi K, Yamanaka M, Kushima M, Nomoto K, Morotomi M (2000) The effect of an oral administration of Lactobacillus casei strain shirota on azoxymethane-induced colonic aberrant crypt foci and colon cancer in the rat. Oncol Rep 7(5):977–982Google Scholar
  136. Yokokura T (1994) Antitumour and immunostimulating activity of Lactobacillus casei. Jpn Dairy Food Sci 43:A141–A150Google Scholar
  137. Young TB, Wolf DA (1988) Case-control study of proximal and distal colon cancer and diet in Wisconsin. Int J Cancer 42:167–175Google Scholar
  138. Zhang XB, Ohta Y, Hosono A (1990) Antimutagenicity and binding of lactic acid bacteria from a Chinese cheese to mutagenic pyrolyzates. J Dairy Sci 73:2702–2710Google Scholar
  139. Zhang XB, Ohta Y (1991) In vitro binding of mutagenic pyrolyzates to lactic acid bacterial cells in human gastric juice. J Dairy Sci 74:752–757Google Scholar
  140. Zhang XB, Ohta Y (1993) Microorganisms in the gastrointestinal tract of the rat prevent absorption of the mutagen-carcinogen 3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole. Can J Microbiol 39:841–845Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Philip Allsopp
    • 1
  • Ian Rowland
    • 2
  1. 1.Northern Ireland Centre for Food and Health, Centre for Molecular BiosciencesUniversity of UlsterColeraineUK
  2. 2.Hugh Sinclair Unit for Human Nutrition, Department of Food BiosciencesUniversity of ReadingWhiteknightsUK

Personalised recommendations